Aller au contenu principal
Profil bibliographique

Xueyi Weng

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

21Publications signalées
538Citations signalées
4Affiliations récentes

Les institutions déclarées

Les domaines associés

Phagocytosis and Immune RegulationExtracellular vesicles in diseaseImmune cells in cancerCardiac Fibrosis and RemodelingCoronary Interventions and Diagnostics

Les publications récentes

Accès ouvert 2026 article OpenAlex

A Dual‐Phase Exosomal Nanotherapy Enhances Continual Efferocytosis by Coordinating Checkpoint Inhibition and Metabolic Reprogramming in Atherosclerosis

Danwen Zheng, Shiteng Cai, Jian Gao, Sheng Zhao et autres

ABSTRACT Atherosclerosis is a chronic inflammatory disease characterized by defective efferocytosis, which contributes to necrotic core expansion and plaque instability. This dysfunction arises from two key barriers: first, impaired recognition of apoptotic cells due to activation of the CD47–SIRPα immune checkpoint; and …

cn (code pays fourni par la source)

1 citation Advanced Science
2025 conference-abstract OpenAlex

Abstract 4368865: Ly6C-Targeted LNP Delivery of CAR-ABCA1 mRNA Reprograms Macrophages for Enhanced Efferocytosis and Cholesterol Efflux in Atherosclerosis

Weiyan Li, Xueyi Weng, Juying Qian

Introduction: Atherosclerosis (AS) is a chronic inflammatory disease characterized by lipid accumulation and defective clearance of apoptotic cells in plaques. Traditional LDL-C-lowering therapies such as statins show limited efficacy, as they fail to correct underlying metabolic imbalances. These imbalances cause anti-inflammatory macrophages …

cn (code pays fourni par la source)

0 citations Circulation
2025 conference-abstract OpenAlex

Abstract 4362785: In vivo generation of CAR-M via LNP-mRNA targeting macrophages for immunotherapy in cardiac repair

Xueyi Weng

Background: Inflammatory response is a crucial mechanism in the development and progression of heart failure following ischemic cardiac injury, partly because the delayed clearance of apoptotic cells triggers excessive inflammation. Under normal circumstances, efferocytosis by macrophages mediates the active removal of apoptotic …

cn (code pays fourni par la source)

1 citation Circulation
Accès ouvert 2025 article OpenAlex

Synergistic enhancement of efferocytosis and cholesterol efflux via macrophage biomimetic nanoparticle to attenuate atherosclerosis progression

Shiteng Cai, Jinfeng Gao, Xueyi Weng, Zhengmin Wang et autres

Atherosclerosis is the leading cause of myocardial infarction and stroke, which is characterized as a chronic inflammatory disease due to the aberrant accumulation of apoptotic cells in the necrotic core. Previous CD47-SIRPα checkpoint blockage strategies based on monoclonal antibodies or nanoparticles have …

cn, us, kr (code pays fourni par la source)

11 citations Bioactive Materials
Accès ouvert 2024 article OpenAlex

Biomimetic Nano‐Degrader Based CD47‐SIRPα Immune Checkpoint Inhibition Promotes Macrophage Efferocytosis for Cardiac Repair

Jinfeng Gao, Zhiqing Pang, Qiaozi Wang, Yiwen Tan et autres

CD47-SIRPα axis is an immunotherapeutic target in tumor therapy. However, current monoclonal antibody targeting CD47-SIRPα axis is associated with on-target off-tumor and antigen sink effects, which significantly limit its potential clinical application. Herein, a biomimetic nano-degrader is developed to inhibit CD47-SIRPα axis …

cn, kr (code pays fourni par la source)

25 citations Advanced Science
Accès ouvert 2024 article OpenAlex

Genetically Engineered Macrophages Co‐Loaded with CD47 Inhibitors Synergistically Reconstruct Efferocytosis and Improve Cardiac Remodeling Post Myocardial Ischemia Reperfusion Injury

Haipeng Tan, Weiyan Li, Zhiqing Pang, Xueyi Weng et autres

Efferocytosis, mediated by the macrophage receptor MerTK (myeloid-epithelial-reproductive tyrosine kinase), is a significant contributor to cardiac repair after myocardial ischemia-reperfusion (MI/R) injury. However, the death of resident cardiac macrophages (main effector cells), inactivation of MerTK (main effector receptor), and overexpression of "do …

cn, kr (code pays fourni par la source)

34 citations Advanced Healthcare Materials
2023 article OpenAlex

Early initiation of ARBs without blood pressure risk via neutrophil membrane-fused pH-sensitive liposomes to reduce cardiomyocyte apoptosis after acute myocardial infarction

Jinfeng Gao, Wusiman Yakufu, Hongbo Yang, Yanan Song et autres

Activation of the local renin–angiotensin system (RAS) promotes cardiomyocyte apoptosis and cardiac remodeling after acute myocardial infarction (AMI). As an anti-RAS drug, the effect of Valsartan in the early stage of acute MI is limited by its low drug concentration in the …

cn (code pays fourni par la source)

12 citations Nano Research
Accès ouvert 2022 article OpenAlex

The Peripandemic Impact of the First Wave of the COVID-19 Pandemic on Management and Prognosis of ST-Segment Elevation Myocardial Infarction in China

Hongbo Yang, Lingfeng Luo, Jiatian Cao, Yanan Song et autres

BACKGROUND: Rapid reperfusion of ST-segment elevation myocardial infarction (STEMI) has been challenging during the coronavirus disease 2019 (COVID-19) outbreak. Whether and to what degree there will be a residual impact when the COVID-19 pandemic has passed is unclear. METHODS: This nationwide retrospective …

cn (code pays fourni par la source)

2 citations Journal of Clinical Medicine

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.